Etoposide Injection
-
Generic name
etoposide
-
Brand reference
Vepesid®
-
Strength
20 mg/mL
-
DIN
02080036
-
Therapeutic class
Antineoplastic Agent
-
Therapeutic area
Oncology
-
Package size
Vial 5 mL
Vial 50 mL
Vial 10 mL
Vial 25 mL
-
Product code
72102-0005
72102-0033
72102-0010
72102-0025
-
UPC
068510645050
068510645333
068510645104
068510645258
-
Generic name:
etoposide
-
Brand reference:
Vepesid®
-
Product code:
72102-0005
72102-0033
72102-0010
72102-0025
-
Strength
20 mg/mL
-
DIN
02080036
-
UPC:
068510645050
068510645333
068510645104
068510645258
-
Therapeutic class
Antineoplastic Agent
-
Therapeutic area:
Oncology
-
Package size:
Vial 5 mL
Vial 50 mL
Vial 10 mL
Vial 25 mL
Composition
Active ingredient
etoposide
Non-medicinal ingredients
2 mg citric acid, anhydrous; 80 mg polysorbate 80; 241 mg absolute ethanol and polyethylene glycol 300.
Product characteristics
-
Dosage form
solution for injection
-
Shape
-
Marking 1
-
Marking 2
-
Colour
-
Secondary colour
-
Scored
-
Flavour
-
Gluten
currently not available
-
Latex
no
Disclaimers
All information about raw materials and / or allergen information for Teva Canada’s products is obtained from our suppliers and/or third party affiliates and is based on their records.
Please be advised that the Medical Information department is not always notified of change in third party affiliates and / or change in suppliers of the excipients that may occur over time, and all information provided herein is based on our last current records.
"Latex" – refers to NATURAL RUBBER LATEX. We cannot guarantee that there is no latex in the outer packaging or that the medication or packaging haven’t come into contact with latex at any point during the manufacturing process, however this is very unlikely due to the strict GMP procedures that are in place in all of our manufacturing facilities. Employees in the manufacturing and / or packaging facilities may be wearing latex gloves
Product monograph/consumer information leaflet
View monograph
Notice
We are modifying our product names to align with our corporate name change. Accordingly, please expect product monographs to contain the “Novo-”, “ratio-”, “ACT”, "CO" prefix or the new “Teva” prefix. These prefixes may be used interchangeably on the website.
Should you have any questions about our product names or our corporate name change, please do not hesitate to contact us. Our Customer Care department can be reached at 1-800-268-4127 regarding your inquiry.